![EU approved biosimilars are interchangeable with reference medicines/ equivalent biosimilar: EMA, HMA, Health News, ET HealthWorld EU approved biosimilars are interchangeable with reference medicines/ equivalent biosimilar: EMA, HMA, Health News, ET HealthWorld](https://etimg.etb2bimg.com/thumb/msid-94324477,imgsize-50022,width-1200,height-628,overlay-ethealthworld/eu-approved-biosimilars-are-interchangeable-with-reference-medicines-equivalent-biosimilar-ema-hma.jpg)
EU approved biosimilars are interchangeable with reference medicines/ equivalent biosimilar: EMA, HMA, Health News, ET HealthWorld
![European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases](https://www.ejprarediseases.org/wp-content/uploads/2021/10/EMApilotproject-e1635930571908-1200x600.png)
European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases
![Flowchart of included drugs. EMA, European Medicines Agency; FDA, Food... | Download Scientific Diagram Flowchart of included drugs. EMA, European Medicines Agency; FDA, Food... | Download Scientific Diagram](https://www.researchgate.net/publication/264936913/figure/fig1/AS:669138200559621@1536546387338/Flowchart-of-included-drugs-EMA-European-Medicines-Agency-FDA-Food-and-Drug.png)
Flowchart of included drugs. EMA, European Medicines Agency; FDA, Food... | Download Scientific Diagram
![EMA is launching a pilot to support the repurposing of established medicines for use in new indications by NGOs and academia. | ERICA EMA is launching a pilot to support the repurposing of established medicines for use in new indications by NGOs and academia. | ERICA](https://erica-rd.eu/wp-content/uploads/2021/12/EMA-medicines-768x432.jpg)
EMA is launching a pilot to support the repurposing of established medicines for use in new indications by NGOs and academia. | ERICA
EU Medicines Agency on Twitter: "EMA's safety committee, the #PRAC, starts review of #terlipressin medicines and recommends updates to product information for some #COVID19vaccines: 👉https://t.co/EFGDJII0Xt #SafetyOfVaccines https://t.co/wLcVnqYMDs ...
![European Medicines Agency (EMA) | CDE Almería - Centro de Documentación Europea - Universidad de Almería European Medicines Agency (EMA) | CDE Almería - Centro de Documentación Europea - Universidad de Almería](https://www.cde.ual.es/wp-content/uploads/2022/07/ema-logo-1024x455-1.webp)